Skip to main content
Premium Trial:

Request an Annual Quote

AstraZeneca to Use Eidogen-Sertanty s Informatics System

NEW YORK, Dec. 15 (GenomeWeb News) - AstraZeneca will use Eidogen-Sertanty's target informatics platform for its drug-discovery efforts, Eidogen-Sertanty said today.


Under the agreement, scientists at AstraZeneca R&D Boston will access the protein structure informatics system and the EVE Comparative Visualization software within their cancer and anti-infective therapeutic programs.


Financial terms were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.